These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 14700735)
1. Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats. Verty AN; McGregor IS; Mallet PE Neurosci Lett; 2004 Jan; 354(3):217-20. PubMed ID: 14700735 [TBL] [Abstract][Full Text] [Related]
2. Characterization of a shortened model of diet alternation in female rats: effects of the CB1 receptor antagonist rimonabant on food intake and anxiety-like behavior. Blasio A; Rice KC; Sabino V; Cottone P Behav Pharmacol; 2014 Oct; 25(7):609-17. PubMed ID: 25011007 [TBL] [Abstract][Full Text] [Related]
3. Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats. Rowland NE; Mukherjee M; Robertson K Psychopharmacology (Berl); 2001 Dec; 159(1):111-6. PubMed ID: 11797078 [TBL] [Abstract][Full Text] [Related]
4. Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide. Cani PD; Montoya ML; Neyrinck AM; Delzenne NM; Lambert DM Br J Nutr; 2004 Nov; 92(5):757-61. PubMed ID: 15533263 [TBL] [Abstract][Full Text] [Related]
5. Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Colombo G; Agabio R; Diaz G; Lobina C; Reali R; Gessa GL Life Sci; 1998; 63(8):PL113-7. PubMed ID: 9718088 [TBL] [Abstract][Full Text] [Related]
6. Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats. Maccioni P; Pes D; Carai MA; Gessa GL; Colombo G Behav Pharmacol; 2008 May; 19(3):197-209. PubMed ID: 18469537 [TBL] [Abstract][Full Text] [Related]
7. The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats. McLaughlin PJ; Winston K; Swezey L; Wisniecki A; Aberman J; Tardif DJ; Betz AJ; Ishiwari K; Makriyannis A; Salamone JD Behav Pharmacol; 2003 Dec; 14(8):583-8. PubMed ID: 14665975 [TBL] [Abstract][Full Text] [Related]
8. Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole--LH 21. Pavon FJ; Bilbao A; Hernández-Folgado L; Cippitelli A; Jagerovic N; Abellán G; Rodríguez-Franco MA; Serrano A; Macias M; Gómez R; Navarro M; Goya P; Rodríguez de Fonseca F Neuropharmacology; 2006 Aug; 51(2):358-66. PubMed ID: 16750544 [TBL] [Abstract][Full Text] [Related]
9. Blockade by the cannabinoid CB(1) receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats. Serra S; Brunetti G; Pani M; Vacca G; Carai MA; Gessa GL; Colombo G Eur J Pharmacol; 2002 May; 443(1-3):95-7. PubMed ID: 12044797 [TBL] [Abstract][Full Text] [Related]
10. The inverse agonist of CB1 receptor SR141716 blocks compulsive eating of palatable food. Dore R; Valenza M; Wang X; Rice KC; Sabino V; Cottone P Addict Biol; 2014 Sep; 19(5):849-61. PubMed ID: 23587012 [TBL] [Abstract][Full Text] [Related]
11. The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats. Sink KS; McLaughlin PJ; Wood JA; Brown C; Fan P; Vemuri VK; Peng Y; Olszewska T; Thakur GA; Makriyannis A; Parker LA; Salamone JD Neuropsychopharmacology; 2008 Mar; 33(4):946-55. PubMed ID: 17581535 [TBL] [Abstract][Full Text] [Related]
12. Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats. Vickers SP; Webster LJ; Wyatt A; Dourish CT; Kennett GA Psychopharmacology (Berl); 2003 Apr; 167(1):103-11. PubMed ID: 12632249 [TBL] [Abstract][Full Text] [Related]
13. Cannabinoid modulation of rat pup ultrasonic vocalizations. McGregor IS; Dastur FN; McLellan RA; Brown RE Eur J Pharmacol; 1996 Oct; 313(1-2):43-9. PubMed ID: 8905327 [TBL] [Abstract][Full Text] [Related]
14. Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716. Colombo G; Agabio R; Fà M; Guano L; Lobina C; Loche A; Reali R; Gessa GL Alcohol Alcohol; 1998; 33(2):126-30. PubMed ID: 9566474 [TBL] [Abstract][Full Text] [Related]
15. Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A. De Vry J; Schreiber R; Eckel G; Jentzsch KR Eur J Pharmacol; 2004 Jan; 483(1):55-63. PubMed ID: 14709326 [TBL] [Abstract][Full Text] [Related]
16. Stimulation of accumbens shell cannabinoid CB(1) receptors by noladin ether, a putative endocannabinoid, modulates food intake and dietary selection in rats. Deshmukh RR; Sharma PL Pharmacol Res; 2012 Sep; 66(3):276-82. PubMed ID: 22728691 [TBL] [Abstract][Full Text] [Related]
17. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems. Solinas M; Goldberg SR Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567 [TBL] [Abstract][Full Text] [Related]
18. The effect of am 251, a cannabinoid CB1 receptor antagonist, on food intake in rats. Rutkowska M Acta Pol Pharm; 2004; 61(5):401-3. PubMed ID: 15747698 [TBL] [Abstract][Full Text] [Related]
19. Boosting effect of morphine on alcohol drinking is suppressed not only by naloxone but also by the cannabinoid CB1 receptor antagonist, SR 141716. Vacca G; Serra S; Brunetti G; Carai MA; Gessa GL; Colombo G Eur J Pharmacol; 2002 Jun; 445(1-2):55-9. PubMed ID: 12065194 [TBL] [Abstract][Full Text] [Related]
20. The effects of leptin in combination with a cannabinoid receptor 1 antagonist, AM 251, or cannabidiol on food intake and body weight in rats fed a high-fat or a free-choice high sugar diet. Wierucka-Rybak M; Wolak M; Bojanowska E J Physiol Pharmacol; 2014 Aug; 65(4):487-96. PubMed ID: 25179081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]